Search
Disclaimer
Clicking the images or links will redirect you to a website hosted by BenchSci that provides third-party scientific content. Neither the content nor the BenchSci technology and processes for selection have been evaluated by us; we are providing them as-is and without warranty of any kind, including for use or application of the Thermo Fisher Scientific products presented.
Invitrogen
SPRYD7 Monoclonal Antibody (2G4)
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
产品信息
MA5-22347
产品规格
种属反应
Human,
Rat
宿主/亚型
Mouse
/ IgG1, kappa
分类
Monoclonal
类型
Antibody
克隆号
2G4
抗原
C13orf1 (NP_065189, 97 a.a. ~ 196 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
偶联物
形式
Liquid
浓度
1.0 mg/mL
纯化类型
Affinity chromatography
保存液
PBS, pH 7.4
内含物
no preservative
保存条件
-20°C, Avoid Freeze/Thaw Cycles
运输条件
Ambient (domestic); Wet ice (international)
RRID
产品详细信息
Peptide Sequence: MHSLVMRNDG ALYHNNEEKN RLPANSLPQE GDVVGITYDH VELNVYLNGK NMHCPASGIR GTVYPVVYVD DSAILDCQFS EFYHTPPPGF EKILFEQQIF
靶标信息
C13orf1, also named as SPRYD7 and CLLD6, is involved in hematopoiesis via NOTCH signaling. C13orf1 plays an important role in the pathogenesis of B-CLL. There are isoforms of C13orf1 with MW 15-17 kDa and 19-22 kDa.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
篇参考文献 (0)
您是否在文献中引用过该产品？请点击下方按钮邮件告知我们。
生物信息学
蛋白别名: Chronic lymphocytic leukemia deletion region gene 6 protein; Chronic lymphocytic leukemia deletion region gene 6 protein homolog; CLL deletion region gene 6 protein; CLL deletion region gene 6 protein homolog; PUR1; SPRY domain-containing protein 7
基因别名: C13orf1; CLLD6; RGD1306437; SPRYD7
UniProt ID: (Human) Q5W111, (Rat) Q5M7T2
Entrez Gene ID: (Human) 57213, (Rat) 290303
